PYPD
PYPD
NASDAQ · Pharmaceuticals

Polypid Ltd

$4.44
-0.06 (-1.33%)
As of May 9, 2:10 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +749.3% upside
Low Target $24.55
Average Target $37.71
High Target $48.03
Current Price $4.44
Current
$4.44
Target
$37.71
$24.55 $37.71 avg $48.03
Scenario Analysis
Bear Case
$24.55
452.9%
Low target
Base Case
$37.71
+749.3%
Avg target
Bull Case
$48.03
+981.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.12
-13.3% from high
52-Week Low
$2.44
+82.0% from low
Target vs 52W High
$37.71
+636.5% vs high
Next Earnings Report
May 13, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.44
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%